Veradigm (NASDAQ:MDRX) Now Covered by StockNews.com

StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRXGet Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the software maker’s stock.

Other analysts also recently issued research reports about the stock. TD Cowen decreased their price objective on shares of Veradigm from $26.00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday, May 28th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $10.00 price target (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $12.00.

View Our Latest Analysis on Veradigm

Veradigm Price Performance

Shares of MDRX opened at $9.50 on Thursday. The company’s fifty day simple moving average is $8.73 and its 200-day simple moving average is $8.64. Veradigm has a twelve month low of $5.01 and a twelve month high of $14.09.

Hedge Funds Weigh In On Veradigm

Institutional investors have recently modified their holdings of the stock. TFO Wealth Partners LLC grew its stake in Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after purchasing an additional 5,264 shares in the last quarter. Gladius Capital Management LP grew its position in shares of Veradigm by 135.0% during the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after buying an additional 3,587 shares in the last quarter. Meadow Creek Wealth Advisors LLC purchased a new position in shares of Veradigm during the first quarter valued at $83,000. Headlands Technologies LLC raised its holdings in shares of Veradigm by 14,907.7% in the fourth quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock valued at $102,000 after acquiring an additional 9,690 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Veradigm in the third quarter worth about $189,000.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

See Also

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.